Stay updated with breaking news from David Feifel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A growing number of companies are exploring the possibility of offering psychedelic drug therapy for their employees as a cost-saving and effective means of mental health treatment, according to a report.
Psychotropic drugs are all the rage now as a potential treatment of brain diseases. Examples are ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have a long-lasting effect on generalized anxiety disorder. Some simple chemistry may explain how LSD can persist in the brain long after it is gone from the blood.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.